Sonelokimab (ALX 0761; M 1095) 是一种三价纳米抗体，由单价骆驼来源的纳米抗体组成，对人白介素 (IL)-17A、IL-17F 和人血清白蛋白 VHH 具有特异性。Sonelokimab 具有用于斑块型银屑病研究的潜力。
| 生物活性 | Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody comprised of monovalent camelid-derived nanobodies specific to human interleukin (IL)-17A,IL-17F, and human serum albumin VHHs. Sonelokimab has the potential for plaque-type psoriasis research[1][2]. |
| IC50& Target[1][2] | |
| CAS 号 | |
| 中文名称 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com